VS

Vivek Shrivastava

Active Director Director DIN 10156278
DIN 10156278 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Vivek Shrivastava

Data last updated:

Vivek Shrivastava is a Director at Rewati Nursing Home Private Limited (since 2023). Rewati Nursing Home Private Limited reported revenue of ₹3.82 Cr (FY 2025).

DIN 10156278
Primary Designation Director
First Appointment 10 May 2023
Oldest Company Age 3 yrs
Largest company Rewati Nursing Home Private Limited · ₹3.82 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rewati Nursing Home Private Limited U86100UT2023PTC015614
Director10 May 20232023₹3.82 Cr (FY 2025)Active

Board colleagues of Vivek Shrivastava

NameDINCompanyDesignation
Ruchika Garg10156279Rewati Nursing Home Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rewati Nursing Home Private Limited
Premium access

Shareholding and investment profile for Vivek Shrivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Shrivastava

Vivek Shrivastava currently holds 1 directorship: Rewati Nursing Home Private Limited (Director, since 10 May 2023, revenue ₹3.82 Cr (FY 2025)).

Vivek Shrivastava was first appointed on 10 May 2023 as Director at Rewati Nursing Home Private Limited.

The current boards of Vivek Shrivastava's companies include Ruchika Garg (Rewati Nursing Home Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available